SUBSCRIBE

The Asian Scientist 100

See full list here
Previous profile Next profile
Lu Ke

Institution
Chinese Academy of Sciences

Country
China

Field
Materials Sciences

Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.

(Photo: Future Science Prize)

AWARDS
  • Future Science Prize 2020

Related articles
Technology

A Robotic Millipede That Delivers Drugs

Researchers in Hong Kong have invented a tiny robot with soft caterpillar-like legs that can cross obstacles inside the body and carry heavy loads.
In the Lab

Protecting Probiotic Bacteria From The Stomach

Scientists in China have encapsulated probiotics in a cellulose-alginate gel to allow the bacteria to withstand acidic conditions in the stomach.
Health

Public Trust In Vaccines Plummets After Dengvaxia Controversy

Confidence in vaccine safety and efficacy have declined precipitously following the Dengvaxia scandal in 2017.
In the Lab

World’s First Mice Born To Same-Sex Parents

Chinese scientists have created mouse pups with same-sex parents using haploid embryonic stem cells and gene editing.
Pharma

WuXi AppTec Launches Drug Screening Library

The DNA-Encoded Library platform consists of 80 billion unique molecules which are structurally diverse and chemically exclusive.
In the Lab

Skin Hardness A Better Measure Of Body Temperature

Scientists in South Korea have found that human body temperature can be better estimated by measuring skin hardness in addition to skin temperature and sweat rate.
Features

Discoverer Of GFP Osamu Shimomura Dies At 90 (In Memoriam)

Professor Osamu Shimomura’s discovery of green fluorescent protein in 1962 continues to shed light on the biomolecular pathways of biology.
In the Lab

Cleaner Power Sources Could Save 26 Million Years Of Life

Eliminating emissions by switching to cleaner power sources could add years to people’s lives in China and India, according to a study by scientists in the US.
In the Lab

Making Lung Cancer Immunotherapy More Personal

Patient responses could be better assessed by monitoring nivolumab binding to T-cells as well as the proliferation status of T-cells, researchers say.